Abstract: Described are MMP8 inactivating antigen binding proteins, such as antigen binding proteins comprising an amino acid sequence that comprises 4 framework regions and 3 complementary determining regions; further described is the use of such antigen binding proteins to treat inflammation, such as, but not limited to, systemic inflammatory response syndrome, sepsis, LPS induced inflammation, renal ischemia/reperfusion injury, ventilation induced lung injury, periodontal inflammation, rheumatoid arthritis, multiple sclerosis, ankylosing spondylitis, Lyme arthritis and osteoarthritis.

Abstract: Described are MMP8 inactivating antigen binding proteins, such as antigen binding proteins comprising an amino acid sequence that comprises 4 framework regions and 3 complementary determining regions; further described is the use of such antigen binding proteins to treat inflammation, such as, but not limited to, systemic inflammatory response syndrome, sepsis, LPS induced inflammation, renal ischemia/reperfusion injury, ventilation induced lung injury, periodontal inflammation, rheumatoid arthritis, multiple sclerosis, ankylosing spondylitis, Lyme arthritis and osteoarthritis.

Abstract: The present invention relates to a blood marker for early detection and diagnosis of Alzheimer's disease. More specifically, it relates to an analysis of the protein glycan profile in the blood, and the identification of specific peak ratio's when compared to healthy aged matched subjects that are typical for Alzheimer's dementia.

Abstract: The present invention relates to the use of the A20-binding inhibitor of NF-?B activation (ABIN), or a functional fragment or variant thereof to protect against TNF-induced liver failure, such as viral hepatitis and alcoholic liver disease. More particularly, it relates to the prevention of the toxic effects of said diseases, including lethality, by overexpressing ABIN.

Abstract: The present invention relates to the use of the A20-binding inhibitor of NF-&kgr;B activation (ABIN), or a functional fragment or variant thereof to protect aGalNst TNF-induced liver failure, such as viral hepatitis and alcoholic liver disease. More particularly, it relates to the prevention of the toxic effects of said diseases, including lethality, by overexpressing ABIN.

Abstract: Tension clamp of the type including a sheath provided with an anchoring element and a tapered cavity inclined at a slight angle. In the cavity is a slidably mounted, transversely movable core including a single jaw having an abutting face against the cable. A part of the cavity of the sheath serves as a cradle for the cable and has a substantially semicylindrical cross-section with a radius matching that of the cable. A shell is provided between the part of the cavity of the sheath serving as a cradle for the cable and the cable. The shell is connected axially to the single jaw so as to follow its lengthwise movements, namely those parallel to the cable, but which is displaceable perpendicular to the lengthwise movements.

Abstract: Tension clamp having a sheath provided with a tapered cavity inclined at a slight angle, opened by a lengthwise slit in which is slidably mounted a transversely movable core having a single jaw. An abutting face of the jaw facing a cable is equipped with a bar having a serration in a free face. A bearing face of the single jaw abutting a tapered bearing part of the cavity and the tapered bearing part have matching semicylindrical cross-sections and a common lengthwise axis. The tip of each serration is sloped such that its point of contact with the cable is offset toward a bottom of the cavity opposite lengthwise slit, relative to a diametral plane which contains the axis of the bearing face of the jaw and the axis of the cable.